Sodium, defined in plain electrolyte terms
Serum sodium measures the concentration of sodium ions in your blood, expressed in milliequivalents per liter (mEq/L). Sodium is the body's primary extracellular electrolyte — it lives mostly outside your cells, helping maintain fluid balance, nerve conduction, and muscle contraction. The kidneys, adrenal glands, and brain work constantly to keep sodium within a narrow range, typically around 135–145 mEq/L, though reference intervals vary slightly by laboratory. That tight regulation matters: too little sodium and cells swell with excess water; too much and they shrink from dehydration — both extremes can impair brain, heart, and muscle function within hours.
How serum sodium reflects fluid and hydration balance
Think of sodium as your body's battery fluid. It keeps electrical signals firing across nerve cells and muscles, including the heart. When you move, think, or sweat, sodium moves too — flowing in and out of cells to generate the voltage shifts that make life possible.
Water follows sodium like a magnet, which is why serum sodium tells you as much about hydration and kidney function as about anything else. When sodium drifts high, it often means the body is losing more water than salt — through dehydration or diuretics. When sodium drops, the body may be retaining excess water or losing sodium through sweat, illness, or certain medications. These shifts are governed by antidiuretic hormone (ADH) and the renin-angiotensin-aldosterone system (RAAS), which together respond within hours to days to changes in fluid status.
Serum sodium does not directly reflect dietary salt intake — healthy kidneys regulate serum concentration regardless of how much salt you consume.
Sodium balance is also a marker of systemic regulation — the ability of your kidneys, hormones, and cardiovascular system to maintain internal order under stress. In longevity research, maintaining stable sodium within range is associated with fewer cardiovascular events, likely because proper electrolyte balance stabilizes blood pressure and hydration dynamics over time.
Reading your sodium number in context
Normal range
The reference range — 135–145 mEq/L — is narrow for a reason; the brain and heart depend on it. Exact cutoffs vary slightly by laboratory, so results should always be interpreted against the reference interval on your report. Context also matters: endurance athletes, people in hot climates, and those on low-carb or diuretic regimens may sit at different points within the range depending on their hydration and activity status at the time of the draw.
High serum sodium (hypernatremia)
Hypernatremia — sodium above 145 mEq/L — usually reflects water loss outpacing sodium loss. Common causes include dehydration from heat, exercise, fever, or insufficient fluid intake. Less commonly, it results from hormonal imbalances such as low ADH (antidiuretic hormone). Symptoms include thirst, fatigue, and confusion; in severe cases, muscle twitching or seizures can occur. Clinical management of persistent hypernatremia is directed by the underlying cause, and persistent elevation suggests kidney or adrenal dysfunction warranting medical follow-up.
Low serum sodium (hyponatremia)
Hyponatremia — sodium below 135 mEq/L — occurs when the body retains too much water or loses too much sodium. It is common in endurance athletes who replace fluid without replacing electrolytes, and in conditions such as adrenal insufficiency, heart failure, or use of certain medications including SSRIs and diuretics. Symptoms range from mild fatigue and nausea to confusion, headache, and in extreme cases, cerebral edema. Persistent hypernatremia or hyponatremia warrants evaluation of the underlying mechanism, and rapid correction can be dangerous.
Factors that move sodium up or down between draws
Because sodium is tightly regulated by ADH and the RAAS axis, most day-to-day variation in a serum result reflects acute changes in fluid status, medications, or physiological stress rather than long-term dietary patterns.
- Medications: Diuretics (thiazide and loop) are among the most common causes of low serum sodium, promoting renal sodium excretion. SSRIs can trigger syndrome of inappropriate ADH secretion (SIADH), causing dilutional hyponatremia. Corticosteroids and certain blood pressure medications can raise sodium by promoting retention.
- Kidney function: The kidneys are the primary regulators of sodium excretion. Impaired renal function — from chronic kidney disease or acute injury — disrupts this regulation and can push sodium in either direction depending on the mechanism.
- Exercise-associated hyponatremia: Prolonged endurance exercise, particularly when large volumes of plain water are consumed without electrolyte replacement, can dilute serum sodium significantly. Athletes training in heat can lose 1–2 grams of sodium per liter of sweat, and replacing that volume with water alone lowers serum concentration.
- ADH-affecting conditions: Any condition that stimulates inappropriate ADH release — including heart failure, liver cirrhosis, pulmonary disease, and certain cancers — can cause dilutional hyponatremia by promoting water retention independent of sodium intake.
- Adrenal function: Aldosterone, produced by the adrenal glands, directly governs renal sodium reabsorption. Adrenal insufficiency (low aldosterone) leads to sodium wasting; excess aldosterone (primary hyperaldosteronism) causes sodium retention.
- Stress hormones: Cortisol and aldosterone both influence sodium retention. Chronic physiological stress can alter fluid balance and affect where sodium sits within or outside the reference range.
- Hydration status at draw: Dehydration at the time of the blood draw concentrates all serum values, including sodium. Consistent pre-draw conditions — same time of morning, similar hydration — improve the comparability of serial results.
The electrolyte panel that reads sodium in context
Sodium is rarely interpretable in isolation. The following biomarkers, measured alongside sodium on a basic or comprehensive metabolic panel, provide the context needed to distinguish between causes of dysregulation:
- Potassium — sodium and potassium are regulated in tandem by the renal aldosterone axis; a concurrent low potassium with low sodium points toward diuretic use or adrenal dysfunction rather than simple dehydration.
- Chloride — chloride moves with sodium in most conditions; a sodium-chloride gap can indicate metabolic alkalosis or non-gap acidosis that changes the interpretation.
- Creatinine — rising creatinine alongside rising sodium distinguishes pre-renal dehydration (both rise) from SIADH (sodium falls while creatinine is stable), guiding evaluation.
- Blood urea nitrogen (BUN) — the BUN/creatinine ratio contextualizes whether sodium dysregulation reflects volume depletion vs. inappropriate ADH secretion.
- Carbon dioxide (CO2) — bicarbonate/CO2 completes the basic metabolic panel acid-base picture; alkalosis or acidosis can accompany sodium shifts from diuretics and renal tubular conditions.
When a sodium recheck actually adds information
Sodium is tightly regulated by ADH and the RAAS axis and responds within hours to days to changes in fluid status or medication, making it a snapshot of acute conditions rather than a tractable long-term trend marker. A single out-of-range result in an otherwise healthy person often reflects transient dehydration or pre-draw conditions rather than a persistent problem.
For individuals with stable health and no relevant comorbidities, annual testing as part of a routine metabolic panel is sufficient. More frequent retesting is clinically indicated in the following situations:
- Current use of diuretics, SSRIs, or other medications known to affect sodium
- Diagnosed kidney disease, heart failure, or liver disease
- Following any acute episode of hyponatremia or hypernatremia
- Monitoring during or after a significant change in fluid intake, exercise load, or clinical status
For meaningful comparison across draws, consistent pre-draw conditions matter — same lab, same time of morning, and similar hydration status, since dehydration at the time of draw concentrates serum values and can shift a result within or outside the reference range.
When a sodium result warrants a clinician's review
Sodium testing is one of the simplest yet most essential snapshots of whole-body regulation. It reveals how kidneys, hormones, and hydration work in concert — and tracking it alongside the companion electrolytes above provides early insight into dehydration risk, medication effects, and metabolic stress, often before symptoms arise.
A result outside the 135–145 mEq/L range — particularly if accompanied by symptoms, a concurrent abnormality in potassium, creatinine, or BUN, or a rapid change from a prior value — warrants clinical evaluation. Rapid shifts in sodium in either direction carry neurological risk and should not be managed without medical oversight.
Superpower's comprehensive biomarker panel tracks sodium alongside potassium, chloride, and kidney function markers to map electrolyte health over time. Understanding how hydration, medications, and physiological stress affect these levels is central to the Superpower approach to proactive health. Visit superpower.com to learn more.
```FAQs
References
- Hoorn, E. J., & Zietse, R. (2017). Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines. Journal of the American Society of Nephrology, 28(5), 1340-1349. https://doi.org/10.1681/ASN.2016101139
- Spasovski, G., Vanholder, R., Allolio, B., Annane, D., Ball, S., Bichet, D., Decaux, G., Fenske, W., Hoorn, E. J., Ichai, C., Joannidis, M., Soupart, A., Zietse, R., Haller, M., van der Veer, S., Van Biesen, W., Nagler, E., & Hyponatraemia Guideline Development Group (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrology, dialysis, transplantation, 29 Suppl 2, i1-i39. https://doi.org/10.1093/ndt/gfu040
- Klingert, M., Nikolaidis, P. T., Weiss, K., Thuany, M., Chlíbková, D., & Knechtle, B. (2022). Exercise-Associated Hyponatremia in Marathon Runners. Journal of clinical medicine, 11(22). https://doi.org/10.3390/jcm11226775
- Nagashima, T., Hayakawa, T., Akimoto, H., Minagawa, K., Takahashi, Y., & Asai, S. (2022). Identifying Antidepressants Less Likely to Cause Hyponatremia: Triangulation of Retrospective Cohort, Disproportionality, and Pharmacodynamic Studies. Clinical pharmacology and therapeutics, 111(6), 1258-1267. https://doi.org/10.1002/cpt.2573
- Nagler, E. V., Vanmassenhove, J., van der Veer, S. N., Nistor, I., Van Biesen, W., Webster, A. C., & Vanholder, R. (2014). Diagnosis and treatment of hyponatremia: a systematic review of clinical practice guidelines and consensus statements. BMC medicine, 12, 1. https://doi.org/10.1186/s12916-014-0231-1






































.avif)
